title: Polyhydroxyethylaspartamide-based micelles for ocular drug delivery.
abstract: In this paper three copolymers of polyhydroxyethylaspartamide (PHEA), bearing in the side chains polyethylene glycol (PEG) and/or hexadecylamine (C(16)) (PHEA-PEG, PHEA-PEG-C(16) and PHEA-C(16) respectively) have been studied as potential colloidal drug carriers for ocular drug delivery. The physical characterization of all three PHEA derivatives, using the Langmuir trough (LT) and micellar affinity capillary electrophoresis (MACE) techniques allowed to assume that whereas alone PHEA backbone is an inert polymer with respect to the interactions with lipid membranes and drug complexation, when PHEA chains are grafted with long alkyl chains like C(16) or in combination C(16) chains and hydrophilic chains like PEG, copolymers with lipid membrane interaction ability and drug complexation capability are obtained. In vitro permeability studies performed on primary cultured rabbit conjunctival and corneal epithelia cells, using PHEA-C(16) and PHEA-PEG-C(16) as micelle carriers for netilmicin sulphate, dexamethasone alcohol and dexamethasone phosphate, demonstrated that in all cases drug loaded PHEA-C(16) and PHEA-PEG-C(16) micelles provide a drug permeation across ocular epithelia greater than simple drug solutions or suspensions. In particular PHEA-PEG-C(16) acts as the best permeability enhancer in our experimental model. In vivo bioavailability studies conducted with PHEA-PEG-C(16) micelles loaded with dexamethasone alcohol, confirmed that this system also provides a drug bioavailability greater in comparison with that obtained with water suspension of the same drug after ocular administration to rabbits.
authors.affiliation: RSI, SIFI SpA, Via Ercole Patti, 95022 Lavinaio, CT, Italy.
authors.forename: C
authors.initials: C
authors.lastname: Civiale
authors.forename: M
authors.initials: M
authors.lastname: Licciardi
authors.forename: G
authors.initials: G
authors.lastname: Cavallaro
authors.forename: G
authors.initials: G
authors.lastname: Giammona
authors.forename: M G
authors.initials: MG
authors.lastname: Mazzone
mesh_terms: D000287:Administration, Topical; D000588:Amines / Q000737:chemistry; D000818:Animals; D001682:Biological Availability; D003102:Colloids; D003228:Conjunctiva / Q000378:metabolism; D003907:Dexamethasone / Q000008:administration & dosage / Q000737:chemistry / Q000493:pharmacokinetics; D004337:Drug Carriers / Q000737:chemistry*; D019573:Epithelium, Corneal / Q000378:metabolism; D006838:Hydrocarbons; D008297:Male; D008823:Micelles; D009428:Netilmicin / Q000008:administration & dosage / Q000737:chemistry / Q000493:pharmacokinetics; D010455:Peptides / Q000737:chemistry*; D010539:Permeability; D011092:Polyethylene Glycols / Q000737:chemistry; D011108:Polymers / Q000737:chemistry*; D011817:Rabbits
chemical_list: D000588:Amines; D003102:Colloids; D004337:Drug Carriers; D006838:Hydrocarbons; D008823:Micelles; D010455:Peptides; D011108:Polymers; C008965:alpha,beta-poly((2-hydroxyethyl)-aspartamide); D011092:Polyethylene Glycols; D009428:Netilmicin; D003907:Dexamethasone; C013553:hexadecylamine